Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.
Michael J GandalJillian R HaneyNeelroop N ParikshakVirpi LeppaGokul RamaswamiChris HartlAndrew J SchorkVivek AppaduraiAlfonso A Buil DemurThomas M WergeYanling LiuKevin P Whitenull nullnull nullnull nullSteve HorvathDaniel H GeschwindPublished in: Science (New York, N.Y.) (2018)
The predisposition to neuropsychiatric disease involves a complex, polygenic, and pleiotropic genetic architecture. However, little is known about how genetic variants impart brain dysfunction or pathology. We used transcriptomic profiling as a quantitative readout of molecular brain-based phenotypes across five major psychiatric disorders-autism, schizophrenia, bipolar disorder, depression, and alcoholism-compared with matched controls. We identified patterns of shared and distinct gene-expression perturbations across these conditions. The degree of sharing of transcriptional dysregulation is related to polygenic (single-nucleotide polymorphism-based) overlap across disorders, suggesting a substantial causal genetic component. This comprehensive systems-level view of the neurobiological architecture of major neuropsychiatric illness demonstrates pathways of molecular convergence and specificity.
Keyphrases
- bipolar disorder
- gene expression
- resting state
- major depressive disorder
- white matter
- genome wide
- single cell
- dna methylation
- single molecule
- autism spectrum disorder
- depressive symptoms
- functional connectivity
- healthcare
- transcription factor
- high resolution
- rna seq
- multiple sclerosis
- health information
- physical activity
- sleep quality
- brain injury
- blood brain barrier